Showing results (811-820 of 1,341) with videos related to

Sort By:
Pageof 135
Neuro-Oncology Advances|June 1, 2026
Women in neurosurgical oncology: Mapping the milestones and shaping the futureGrace E Hey, Chloe L DeYoung, Kathleen S Botterbush, et al.
Neuro-Oncology Advances|June 1, 2026
Pre-operative embolization of skull base meningiomasOmar Ashraf, Stacey Q Wolfe, Samuel Emerson, et al.
Neuro-Oncology Advances|June 1, 2026
Cellular senescence escape and antiviral response discriminate glioblastoma from lower-grade gliomasDominika Maurencova, Michaela Sadibolova, Monika Zarska, et al.
Neuro-Oncology Advances|May 25, 2026
Surgical resection or bevacizumab for treatment of radiation necrosis-associated cerebral edema in patients with brain metastases: A single center experienceMiles E Dijkstra, Joost W Schouten, Lotte Plegt, et al.
Neuro-Oncology Advances|May 29, 2026
Predictive radiomics for evaluation of cancer immune signature in glioblastoma: The PRECISE-GBM studyPrajwal Ghimire, Junjie Li, Liu Yaou, et al.
Neuro-Oncology Advances|April 13, 2026
DNA methylation-based deconvolution study of glioblastoma heterogeneity and identification of cell compositions associated with patient survivalAviel Iluz, Nir Lavi, Hanna Charbit, et al.
Neuro-Oncology Advances|March 27, 2026
Delta-like ligand 3 expression in isocitrate dehydrogenase-mutant and isocitrate dehydrogenase-wildtype glioma is largely retained at recurrence, supporting its potential as a therapeutic targetRosa Luning, Sybren L N Maas, Pim J French, et al.
Neuro-Oncology Advances|April 1, 2026
An interpretable machine learning model for identifying granulation patterns in somatotroph tumors: A multi-center radiomics studyJiaming Wang, Le Chen, Qiya He, et al.
Neuro-Oncology Advances|April 30, 2026
A phase 2 study of niraparib concomitant with tumor treating fields in patients with recurrent grade 4 gliomaElizabeth C Cordell, Maikel Mansour, Austin R Pantel, et al.
Neuro-Oncology Advances|April 30, 2026
MEK inhibitors for neurofibromatosis type 1-associated central and peripheral nervous system tumorsChelsea Kotch, Peter de Blank, Jason Fangusaro, et al.
Pageof 135